Jump to ContentJump to Main Navigation

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Schlattmann, Peter / Tate, Jillian R. / Tsongalis, Gregory J.

12 Issues per year


IMPACT FACTOR 2014: 2.707
Rank 6 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR): 0.860
Source Normalized Impact per Paper (SNIP): 1.046

VolumeIssuePage

Issues

Automated Enzymatic Mitochondrial Antibody Assay for the Diagnosis of Primary Biliary Cirrhosis

Wayne A. Jensen / Jennifer A. Jois / Peter Murphy / Joseph De Giorgio / Belinda Brown / Merrill J. Rowley / Ian R. Mackay

Citation Information: Clinical Chemistry and Laboratory Medicine. Volume 38, Issue 8, Pages 753–758, ISSN (Print) 1434-6621, DOI: 10.1515/CCLM.2000.107, June 2005

Publication History

Published Online:
2005-06-01

Abstract

Primary biliary cirrhosis is a progressive autoimmune disease that affects middle aged women, resulting in liver cirrhosis. We describe here an automated enzymatic mitochondrial antibody assay adapted for performance on laboratory analysers for the serological diagnosis of primary biliary cirrhosis. This assay detects the characteristic autoantibody directed against the 74kDa E2 subunit of the pyruvate dehydrogenase complex.

Analysis of receiver operator characteristic curve data indicated that the automated enzymatic mitochondrial assay procedure discriminated clinically identified patients with primary biliary cirrhosis from normal subjects with a sensitivity of 83% and a specificity of 100%. This method compared favourably against a commercial ELISA method which had a sensitivity of 73% and a specificity of 100%. The automated enzymatic mitochondrial antibody assay is a high throughput assay of use for the routine diagnosis of patients with primary biliary cirrhosis with autoantibodies to the E2 subunit of the pyruvate dehydrogenase complex. The method is of potential value for economical and rapid screening to detect asymptomatic primary biliary cirrhosis in the at-risk segment of the population, namely middle aged women.

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Ian R. Mackay
Best Practice & Research Clinical Gastroenterology, 2000, Volume 14, Number 4, Page 519
[2]
HIROAKI HAZAMA, KATSUHISA OMAGARI, JUN-ICHI MASUDA, KAZUO OHBA, HIDEKI KINOSHITA, ISAO MATSUO, HAJIME ISOMOTO, YOHEI MIZUTA, KUNIHIKO MURASE, IKUO MURATA, and SHIGERU KOHNO
Journal of Gastroenterology and Hepatology, 2002, Volume 17, Number 3, Page 316

Comments (0)

Please log in or register to comment.